17 topics with brief breakdowns: definitions, key facts, and class questions.
Chapter 17 is dedicated to one of the most complex and pressing issues in medicine — the pathophysiology of tumor growth. Here, we analyze how a normal cell transforms into a malignant one and study the mechanisms that allow it to survive despite the body's defense barriers.
This section covers the entire lifecycle of neoplasms. We will examine in detail the nature of chemical and physical carcinogens, the balance between oncogenes and tumor suppressor genes, and the sequential stages of carcinogenesis. A key block of the chapter focuses on tumor atypia in all its manifestations: from disorders of protein, lipid, and ion metabolism to functional atypia and invasive growth. You will learn how metastasis occurs, the overall impact of a tumor on the body, and how anti-tumor defense mechanisms operate.
In classes and exams, the fundamental differences between benign and malignant tumors, the mechanisms of metabolic atypia, and the stages of metastasis are traditionally the most frequently asked topics. Be sure to pay attention to risk factors and the principles of anti-tumor immunity — this is the absolute foundation required to understand modern approaches to the prevention and treatment of oncological diseases.
By what criteria is a tumor recognized as malignant?
The status of malignancy is established based on a combination of clinical, morphological, and prognostic criteria. The main signs are poor cellular differentiation, rapid growth, invasion into adjacent tissues, and the ability to metastasize.
What is the difference between local and resorptive action of carcinogens?
Local-action carcinogens (e.g., PAHs) cause a tumor directly at the site of contact with tissue. Resorptive-action substances (aromatic amines) are absorbed, metabolized, and provoke cancer remotely from the site of entry.
Why is a head CT dangerous specifically at a young age?
In individuals under 22 years of age, tissues are more sensitive to ionizing radiation, and the accumulated radiation dose significantly increases the risk of mutations in actively dividing cells.
Can a mutation in just a single oncogene lead to cancer?
No, the development of a full-fledged tumor always requires the interaction of multiple mutated oncogenes and genes regulating proliferation.
Why does Li-Fraumeni syndrome give rise to so many different tumors?
Because the p53 gene is the universal "guardian of the genome." Its defect deprives cells of the ability to repair DNA damage or trigger apoptosis, making them vulnerable to any carcinogens.
Why are tumor markers needed if histological examination is available?
Markers complement histology. They are essential for monitoring treatment efficacy, predicting relapses, and identifying high-risk groups.
Master the entire topic in the "Pathophysiology" course
This is a summary. The course covers everything tested in classes and exams.
4,913 pages of study guides on all topics
Assignments and quizzes after every topic — just like in a colloquium